Stand Up To Cancer (SU2C) has put together an $8 million “dream team” of expert scientists who will focus on discovering new treatments for T-cell lymphoma based on CAR T-cell immunotherapy.
Stand Up To Cancer (SU2C) has put together an $8 million “dream team” of expert scientists who will focus on discovering new treatments for T-cell lymphoma based on CAR T-cell immunotherapy.